Varicose Vein Treatment Industry Forecast to Surpass USD 1,477.3 Million by 2033 at a CAGR of 6.8%

The global varicose vein treatment market is set to witness significant growth over the next decade, with its valuation projected to increase from US$ 765.2 million in 2023 to US$ 1,477.3 million by 2033. This expansion, at a CAGR of 6.8%, highlights the growing demand for advanced treatment options to address varicose veins, a common vascular condition.

Key Market Drivers:

1. Increasing Prevalence of Varicose Veins: A rise in sedentary lifestyles, aging populations, and obesity rates contribute to the increasing incidence of varicose veins globally.
2. Technological Advancements in Treatment: Minimally invasive procedures like endovenous laser treatment (EVLT) and radiofrequency ablation are gaining traction due to their safety, efficacy, and faster recovery times.
3. Growing Awareness and Healthcare Access: Improved awareness of varicose vein complications and enhanced access to healthcare services are driving more patients to seek treatment.
4. Aesthetic Considerations: Increased focus on physical appearance and advancements in cosmetic treatments have further boosted the demand for varicose vein treatment.

    

    

   Regional Outlook:

   • North America: The largest market, driven by high healthcare expenditure, a well-developed healthcare system, and rising cases of varicose veins.
   • Europe: The second-largest market, with increasing demand for minimally invasive treatments and a growing aging population.
   • Asia-Pacific: Poised for rapid growth due to improving healthcare infrastructure, rising awareness, and increasing disposable incomes.

   Challenges:

   1. Cost of Advanced Treatments: High costs of minimally invasive procedures may hinder adoption, particularly in low- and middle-income countries.
   2. Limited Access in Rural Areas: Accessibility issues in remote regions may restrict market growth.

   Future Trends:

   • Integration of AI and Robotics: Emerging technologies are likely to enhance precision and outcomes in varicose vein treatments.
   • Rise in Outpatient Procedures: An increasing number of treatments are being performed in outpatient settings, reducing costs and recovery times.

Growth Drivers

1. Rising Prevalence of Varicose Veins: An increase in the number of individuals affected by varicose veins due to factors such as aging, obesity, and sedentary lifestyles is driving demand for effective treatment options.
2. Advancements in Treatment Technologies: Innovations in treatment methods, particularly endovenous laser systems, which accounted for about 52.47% of the market share in 2022, are enhancing the effectiveness and appeal of varicose vein treatments.
3. Increased Awareness: Growing awareness among patients regarding varicose veins and available treatments is encouraging more individuals to seek medical advice and intervention.
4. Favorable Government Policies: Supportive healthcare policies and favorable reimbursement scenarios in regions like the United States are facilitating access to varicose vein treatments.

Competitive Landscape

Leading players in the market are adopting various organic and inorganic strategies such as new product launches and approvals, mergers, acquisitions, collaborations, and distribution agreements to expand their customer base and gain a competitive edge in the market.

Instances of key developmental strategies by the industry players in the market are given below:

• THERACLION, a pioneering business creating a scalable robotic platform for non-invasive echotherapy, announced the release of SONOVEIN HD in May 2022. This innovative technology combines the first and only extracorporeal therapeutic ultrasound treatment with cutting-edge imaging capabilities from SuperSonic Imagine, a French company based in Aix-en-Provence that Hologic just purchased.
• In April 2022, I-VASC, a medical device company based in Italy, closed a Series A investment worth EUR 1.8 million to bring up its VELEX device, which is used for the treatment of varicose veins.
• The second version of SONOVEIN, THERACLION’s HIFU therapy option for varicose veins, received the CE Mark in October 2020.

Key Players in the Global Market

• AngioDynamics Inc.
• Medtronic
• Syneron Medical Ltd.
• Alma Lasers Ltd.
• Alna-Medicalsystem GmbH
• LSO Medical
• WON TECH Co. Ltd.
• Intros Medical Laser GmbH
• Energist Ltd.
• Dornier Medtech GmbH
• Theraclion
• I-VASC

Market Segmentation

By Product:

• Endovenous Laser Systems
  • Diode Lasers
  • YAG Lasers
• Endovenous Laser Fibres
  • Bare Tip Laser Fibres
  • Radial Tip Laser Fibers
  • Gold Tip Laser Fibres
• Treatment Method
  • Non-thermal Ablation
  • Radiofrequency Ablation
  • Sclerotherapy

By End User:

• Hospitals
• Ambulatory Surgical Centres
• Specialized Clinics

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• The Middle East & Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube